8-K 1 d463046d8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act 1934

Date of Report (Date of earliest event reported): January 7, 2013

Titan Pharmaceuticals, Inc.

(Exact name of registrant as specified in charter)

Delaware |  | 0-27436 |  | 94-3171940
(State or Other Jurisdiction of Incorporation) |  | (Commission File Number) |  | (IRS Employer Identification No.)

400 Oyster Point Blvd., Suite 505, South San Francisco, CA |  | 94080
(Address of Principal Executive Offices) |  | (Zip Code)

Registrant’s telephone number, including area code: 650-244-4990

(Former Name or Former Address, is Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ | Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 | Regulation FD Disclosure

On January 7, 2013, management of Titan Pharmaceuticals, Inc. will be holding investor presentations. A copy of the January 2013 corporate presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. | Financial Statements and Exhibits.

(d) | Exhibits

99.1 |  | Corporate Presentation dated January 2013

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|  |  |  | TITAN PHARMACEUTICALS, INC.
|  |  |  | By: |  | /s/ Sunil Bhonsle
|  |  |  |  |  | Name: Sunil Bhonsle
|  |  |  |  |  | Title: President

Dated: January 7, 2013

Exhibit Index

Exhibit No. |  | Description
99.1 |  | Corporate Presentation dated January 2013